Senti Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €48.58M +176.8% -€79.85M -9.2% -164.4% +3.4 pp N/A N/A
    (estimated) €17.55M +∞% -€87.95M +25.9% -501.1% -5.0 pp N/A N/A
    (estimated) €0.00 -100.0% -€69.86M +16.4% N/A N/A N/A
    (estimated) €2.14M +150.0% -€60.00M +17.5% -2,803.6% +32 pp N/A N/A
    (estimated) €856.09K +∞% -€51.06M +13.0% -5,964.0% -60 pp N/A N/A
    €0.00 -100.0% -€45.19M -43.2% N/A -€35.42M +2.5% N/A
    €2.19M -40.2% -€79.55M +59.6% -3,628.2% -23 pp -€34.55M -723.0% -1,575.8% -17 pp
    €3.67M +87.1% -€49.83M +5.2% -1,358.1% +11 pp €5.55M -122.3% 151.1% +14 pp
    €1.96M +481.5% -€47.36M +178.5% -2,414.6% +26 pp -€24.91M +26.4% -1,269.8% +46 pp
    €337.30K +363.5% -€17.00M -6.1% -5,041.1% +200 pp -€19.70M +40.5% -5,840.6% +130 pp
    €72.77K -€18.11M -24,890.6% -€14.02M -19,272.9%

    Notifications